Product Name
POU4F1, Polyclonal Antibody
Popular Item
Full Product Name
POU4F1 Antibody
Product Synonym Names
Brain specific homeobox/POU domain protein 3A; Brain-3A; Brain-specific homeobox/POU domain protein 3A; Brn 3.0; BRN 3A; Brn-3A; Brn3; BRN3A; class 4; FLJ13449; Homeobox/POU domain protein RDC 1; Homeobox/POU domain protein RDC-1; Homeobox/POU domain protein RDC1; Oct T1; Oct-T1; OctT1; PO4F1_HUMAN; POU class 4 homeobox 1; POU domain; POU Domain Class 4 Transcription Factor 1; Pou4f1; RDC 1; RDC1; transcription factor 1
Product Gene Name
anti-POU4F1 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for Q01851
Species Reactivity
Human, Mouse, Rat
Specificity
POU4F1 antibody detects endogenous levels of total POU4F1
Purity/Purification
The antiserum was purified by peptide affinity chromatography using SulfoLink Coupling Resin.
Form/Format
Liquid
Phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Concentration
1mg/ml (lot specific)
Immunogen
A synthesized peptide
Subcellular Location
Nucleus.
Tissue Specificity
Expressed in the brain and the retina. Present in the developing brain, spinal cord and eye.
Preparation and Storage
Store at -20 degree C. Stable for 12 months from date of receipt.
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Supply Chain Verification
Manufactured in a lab with traceable raw materials manufactured on site. Coordinated product portfolio of antibodies, pairs, conjugates, recombinant proteins, and immunoassay materials available, please inquire.
Other Notes
Small volumes of anti-POU4F1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-POU4F1 antibody
Function: Multifunctional transcription factor with different regions mediating its different effects. Acts by binding (via its C-terminal domain) to sequences related to the consensus octamer motif 5'-ATGCAAAT-3' in the regulatory regions of its target genes. Regulates the expression of specific genes involved in differentiation and survival within a subset of neuronal lineages. It has been shown that activation of some of these genes requires its N-terminal domain, maybe through a neuronal-specific cofactor. Ativates BCL2 expression and protects neuronal cells from apoptosis (via the N-terminal domain). Induces neuronal process outgrowth and the coordinate expression of genes encoding synaptic proteins. Exerts its major developmental effects in somatosensory neurons and in brainstem nuclei involved in motor control. Stimulates the binding affinity of the nuclear estrogene receptor ESR1 to DNA estrogen response element (ERE), and hence modulates ESR1-induced transcriptional activity. May positively regulate POU4F2 and POU4F3. Regulates dorsal root ganglion sensory neuron specification and axonal projection into the spinal cord. Plays a role in TNFSF11-mediated terminal osteoclast differentiation. Negatively regulates its own expression interacting directly with a highly conserved autoregulatory domain surrounding the transcription initiation site.
Subunit Structure: Interacts (via N-terminus) with RIT2; the interaction controls POU4F1 transactivation activity on some neuronal target genes. Isoform 1 interacts with POU4F2; this interaction inhibits both POU4F1 DNA-binding and transcriptional activities. Isoform 1 interacts (C-terminus) with ESR1 (via DNA-binding domain); this interaction decreases the estrogen receptor ESR1 transcriptional activity in a DNA-and ligand 17-beta-estradiol-independent manner.
Similarity: The C-terminal domain is able to act as both DNA-binding domain and a transcriptional activator. The N-terminal domain is also required for transactivation activity on some target genes acting as a discrete activation domain. Neurite outgrowth and expression of genes required for synapse formation are primarily dependent on the C-terminal domain, however the N-terminal domain is required for maximal induction. Belongs to the POU transcription factor family. Class-4 subfamily.
Applications Tested/Suitable for anti-POU4F1 antibody
Western Blot (WB), ELISA (EIA)
Application Notes for anti-POU4F1 antibody
WB: 1:500-1:1000
Western Blot (WB) of anti-POU4F1 antibody
Western blot analysis of extracts from HuvEc cells, using POU4F1 antibody.

Western Blot (WB) of anti-POU4F1 antibody
Western blot analysis of extracts from HuvEc cells, using POU4F1 antibody.

NCBI/Uniprot data below describe general gene information for POU4F1. It may not necessarily be applicable to this product.
NCBI Accession #
NP_006228.3
[Other Products]
NCBI GenBank Nucleotide #
NM_006237.3
[Other Products]
UniProt Primary Accession #
Q01851
[Other Products]
UniProt Secondary Accession #
Q14986; Q15318; Q5T227[Other Products]
UniProt Related Accession #
Q01851[Other Products]
Molecular Weight
Observed: 42 kD
Predicted: 43 kDa
NCBI Official Full Name
POU domain, class 4, transcription factor 1
NCBI Official Synonym Full Names
POU class 4 homeobox 1
NCBI Official Symbol
POU4F1 [Similar Products]
NCBI Official Synonym Symbols
BRN3A; RDC-1; Oct-T1; brn-3A
[Similar Products]
NCBI Protein Information
POU domain, class 4, transcription factor 1
UniProt Protein Name
POU domain, class 4, transcription factor 1
UniProt Synonym Protein Names
Brain-specific homeobox/POU domain protein 3A; Brain-3A; Brn-3A; Homeobox/POU domain protein RDC-1; Oct-T1
Protein Family
POU domain, class 4, transcription factor
UniProt Gene Name
POU4F1 [Similar Products]
UniProt Synonym Gene Names
; Brain-3A; Brn-3A [Similar Products]
NCBI Summary for POU4F1
This gene encodes a member of the POU-IV class of neural transcription factors. This protein is expressed in a subset of retinal ganglion cells and may be involved in the developing sensory nervous system. This protein may also promote the growth of cervical tumors. A translocation of this gene is associated with some ***** acute myeloid leukemias. [provided by RefSeq, Mar 2012]
UniProt Comments for POU4F1
Multifunctional transcription factor with different regions mediating its different effects. Acts by binding (via its C-terminal domain) to sequences related to the consensus octamer motif 5'-ATGCAAAT-3' in the regulatory regions of its target genes. Regulates the expression of specific genes involved in differentiation and survival within a subset of neuronal lineages. It has been shown that activation of some of these genes requires its N-terminal domain, maybe through a neuronal-specific cofactor. Ativates BCL2 expression and protects neuronal cells from apoptosis (via the N-terminal domain). Induces neuronal process outgrowth and the coordinate expression of genes encoding synaptic proteins. Exerts its major developmental effects in somatosensory neurons and in brainstem nuclei involved in motor control. Stimulates the binding affinity of the nuclear estrogene receptor ESR1 to DNA estrogen response element (ERE), and hence modulates ESR1-induced transcriptional activity. May positively regulate POU4F2 and POU4F3. Regulates dorsal root ganglion sensory neuron specification and axonal projection into the spinal cord. Plays a role in TNFSF11-mediated terminal osteoclast differentiation. Negatively regulates its own expression interacting directly with a highly conserved autoregulatory domain surrounding the transcription initiation site.
Research Articles on POU4F1
1. We report a case of a nine-year-old male who presented with facial nerve stimulation four years after cochlear implantation. A dilated internal auditory meatus was revealed. Genetic analysis demonstrated X-linked deafness type 2 (DFNX2) caused by a novel c.769C T nucleotide change in the POU domain, class 3, transcription factor 4 gene
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.